Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

The big pharma sector is one that’s generally fallen out of favor for many investors over the past few decades, as large ...

UnitedHealth declines following a report that the Justice Department has been investigating the company’s Medicare billing ...

Vicor (NASDAQ: VICR) stock is seeing explosive gains in Friday's trading. The power-module specialist's share price was up 18 ...

Markets worldwide defied expectations in 2024 led by the dominating performance of mega-cap technology stocks known as the ...

Over the trailing one-year period, the Ariel Small Cap Value Tax-Exempt Composite advanced +9.60%. Read more here.

ConMed beat Wall Street’s EPS estimates for 2024 and doubled reported EPS from $2.04 in 2023 to $4.25 for 2024.

U.S. stocks tumbled on Friday, extending their selloff in the wake of dour economic reports and closing the book on a holiday ...

The contrasting reactions between the overflow and V.I.P. areas at a Trump event encapsulated the finance world’s worries about the new administration’s first month.

What has Wall Street been buzzing about this week? Here are the top 5 Buy calls and the top 5 Sell calls made by Wall Street’s best analysts ...

Wall Street eased from record highs after Walmart forecasted slower sales, and saw its stock drop. The outlook raised concerns about consumer spending and economic growth, while investors also ...

The legendary investor wrote in Saturday’s annual letter that Berkshire Hathaway will never prefer cash over ‘good businesses ...